InterCure Ltd.
INCR · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $275,799 | $212,611 | $524,903 | $771,571 |
| - Cash | $78,318 | $101,139 | $232,589 | $196,217 |
| + Debt | $211,404 | $195,677 | $255,160 | $108,912 |
| Enterprise Value | $408,885 | $307,149 | $547,474 | $684,266 |
| Revenue | $238,845 | $355,553 | $388,684 | $219,677 |
| % Growth | -32.8% | -8.5% | 76.9% | – |
| Gross Profit | $30,233 | $105,095 | $155,083 | $91,131 |
| % Margin | 12.7% | 29.6% | 39.9% | 41.5% |
| EBITDA | -$51,307 | -$23,900 | $70,230 | $31,172 |
| % Margin | -21.5% | -6.7% | 18.1% | 14.2% |
| Net Income | -$67,795 | -$61,959 | $44,819 | $4,690 |
| % Margin | -28.4% | -17.4% | 11.5% | 2.1% |
| EPS Diluted | -1.42 | -1.36 | 0.99 | 0.11 |
| % Growth | -4.4% | -237.4% | 800% | – |
| Operating Cash Flow | -$66,926 | -$53,631 | $51,267 | $25,020 |
| Capital Expenditures | -$4,376 | -$2,619 | -$19,742 | -$14,029 |
| Free Cash Flow | -$71,302 | -$56,250 | $31,525 | $10,991 |